A detailed history of Qube Research & Technologies LTD transactions in Asensus Surgical, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 129 shares of ASXC stock, worth $45. This represents 0.0% of its overall portfolio holdings.

Number of Shares
129
Previous 129 -0.0%
Holding current value
$45
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.26 - $0.61 $33 - $78
129 New
129 $0
Q4 2022

Feb 14, 2023

SELL
$0.29 - $0.47 $49,127 - $79,620
-169,405 Reduced 90.02%
18,778 $6,000
Q3 2022

Nov 14, 2022

SELL
$0.38 - $0.73 $11,916 - $22,892
-31,359 Reduced 14.28%
188,183 $84,000
Q2 2022

Aug 15, 2022

BUY
$0.37 - $0.61 $81,230 - $133,920
219,542 New
219,542 $87,000
Q2 2021

Aug 13, 2021

SELL
$1.52 - $3.62 $38,714 - $92,201
-25,470 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$0.9 - $6.32 $22,923 - $160,970
25,470 New
25,470 $83,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.